US FDA approves Daiichi, AstraZeneca drug for treatment of solid…
(Reuters) - The U.S. Food and Drug Administration on Friday gave accelerated approval for…
N2:BREACA
Novartis drug cuts recurrence risk by 25% in early-stage breast cancer
By Ludwig Burger FRANKFURT (Reuters) - Novartis breast cancer drug Kisqali cut the risk of…